Albany Medical Center
Albany, New York, 12208, United States
NCT Number: NCT04469868
Opioid analgesics are routinely prescribed for these patients for post-operative pain control. Even a short exposure to opioids in opioid-naïve patients following minor or major surgery has been associated with de novo habitual or persistent use of opioids in 5-30% of patients. The goal of the study to eliminate the use of outpatient opioids prescriptions after major urologic surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Albany, New York, 12208, United States
Nearly 200 million opioid prescriptions are dispensed per year in the United States. Opioid prescriptions given by medical providers are a major contributor to the opioid abuse epidemic. Nearly 40% of opioid overdose-related deaths occur due to prescribed opioids. Among patients diagnosed with opiate dependence, 80% had received an opioid prescription prior to their abuse diagnosis and 51% had a family member who had an opioid prescription, Thus, opioids prescriptions, which are often in excess of the need by the patient, are a major contributor to this public health crisis.
The investigators devised a prospective intervention study to eliminate or significantly reduced the use of opioids prescribed at hospital discharge after major urologic surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients who are being scheduled for any major urologic cancer surgery (open or laparoscopic) will be counselled regarding post-operative pain and measures taken during surgery and during hospital stay.
They will be provided written information on these pain mitigation efforts and the adverse effects associated with opioids use and outpatient prescriptions.
Patients will be discharged from the hospital without any opioids prescriptions and instructions to use non-opioids analgesics.
Patients will complete a visual analog pain scale daily for 7 days after discharge from the hospital.
Patients will be able to call the clinic at anytime for any post-operative pain issues.
Time frame: 30 days
Patients will be discharged with no or few opioids after surgery along with instruction on how to use non-opioid analgesic measures.
Time frame: 30 days
The electronic medical records and pharmacy records will be monitored to identify if any additional opioids prescriptions were provided by any provider
Time frame: 7 days
Visual analog pain scale (which ranges from 0-10) will be completed daily for 7 days. Score of zero signifies no pain at all and a a score of 10 implies the worst pain ever experienced.
Time frame: 7 days
Overall satisfaction score (0-100%) with post-operative pain, discomfort and recovery at home. A higher score signifies more satisfaction with pain control during the recovery process.
Time frame: 30 days
All phone calls to the clinic, unplanned visits, emergency room visits, hospital admissions will recorded and combined as a single measure of contact with any healthcare facility as a measure of resource utilization.
Albany Medical College
Other
Prospective Study of No Opioids PrescrIptions On Discharge After Surgery (NOPIOiDS)
Acronym: NOPIOiDS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03763734
Arthritis, Catastrophizing Pain
Hvidovre, Denmark
View Trial DetailsNCT03763760
Arthritis, Catastrophizing Pain
Hvidovre, Denmark
View Trial DetailsNCT04648774
Neurologic Manifestations, Opioid Use
Halifax, Nova Scotia, Canada
View Trial DetailsNCT05208892
Neurologic Manifestations, Opioid Use
Palo Alto, California, United States
View Trial Details